OBJECTIVES: Propofol is a widely used intravenous anesthetic agent with antioxidant properties. However, the effect of propofol on reactive oxygen species-induced injury in vascular smooth muscle cells is still unknown. In this study, the authors determined the effect of propofol on hydrogen peroxide-induced injury in vascular smooth muscle cells and the potential molecular mechanisms involved. DESIGN: Prospective cell and animal study. SETTING: University research laboratory. SUBJECTS: Sprague-Dawley rats. INTERVENTIONS: For the in vitro study, rat vascular smooth muscle cells pretreated with vehicle or hydrogen peroxide (200 μM) were exposed to vehicle or increasing concentrations of propofol (10-50 μM). For the in vivo study, propofol (12 mg kg⁻¹/hr⁻¹, intravenous) or vehicle was administrated into rats after carotid artery angioplasty. MEASUREMENTS AND MAIN RESULTS: The cell survival and cell death were measured by MTT and trypan blue exclusion. Cell apoptosis was evaluated by terminal deoxynucleotide transferase dUTP nick end labeling staining and cleaved caspase-3 expression. To further elucidate the molecular mechanisms in propofol-mediated cellular effect, the expression of programmed cell death 4 and microRNA-21 were measured. Unexpectedly, propofol exacerbated hydrogen peroxide-induced injury responses in vascular smooth muscle cells as demonstrated by a decrease in cell viability and an increase in trypan blue-stained cells, cell apoptosis, and cleaved caspase-3 expression. In addition, propofol inhibited hydrogen peroxide-induced up-regulation of microRNA-21 and increased its target gene programmed cell death 4. Propofol-mediated injury was attenuated by restoration of microRNA-21 expression. Finally, the pro-injury effect of propofol on vascular cells with increased reactive oxygen species was illustrated in vivo in rat carotid arteries after angioplasty. CONCLUSIONS: The results revealed that propofol exacerbates cell injury in vascular smooth muscle cells with increased reactive oxygen species, at least in part, through microRNA-21 and its target gene, programmed cell death 4. Because increased reactive oxygen species is a common pathologic component in many vascular diseases, the novel findings in the current study suggest that propofol might have some application limitations.
OBJECTIVES:Propofol is a widely used intravenous anesthetic agent with antioxidant properties. However, the effect of propofol on reactive oxygen species-induced injury in vascular smooth muscle cells is still unknown. In this study, the authors determined the effect of propofol on hydrogen peroxide-induced injury in vascular smooth muscle cells and the potential molecular mechanisms involved. DESIGN: Prospective cell and animal study. SETTING: University research laboratory. SUBJECTS:Sprague-Dawley rats. INTERVENTIONS: For the in vitro study, rat vascular smooth muscle cells pretreated with vehicle or hydrogen peroxide (200 μM) were exposed to vehicle or increasing concentrations of propofol (10-50 μM). For the in vivo study, propofol (12 mg kg⁻¹/hr⁻¹, intravenous) or vehicle was administrated into rats after carotid artery angioplasty. MEASUREMENTS AND MAIN RESULTS: The cell survival and cell death were measured by MTT and trypan blue exclusion. Cell apoptosis was evaluated by terminal deoxynucleotide transferase dUTP nick end labeling staining and cleaved caspase-3 expression. To further elucidate the molecular mechanisms in propofol-mediated cellular effect, the expression of programmed cell death 4 and microRNA-21 were measured. Unexpectedly, propofol exacerbated hydrogen peroxide-induced injury responses in vascular smooth muscle cells as demonstrated by a decrease in cell viability and an increase in trypan blue-stained cells, cell apoptosis, and cleaved caspase-3 expression. In addition, propofol inhibited hydrogen peroxide-induced up-regulation of microRNA-21 and increased its target gene programmed cell death 4. Propofol-mediated injury was attenuated by restoration of microRNA-21 expression. Finally, the pro-injury effect of propofol on vascular cells with increased reactive oxygen species was illustrated in vivo in rat carotid arteries after angioplasty. CONCLUSIONS: The results revealed that propofol exacerbates cell injury in vascular smooth muscle cells with increased reactive oxygen species, at least in part, through microRNA-21 and its target gene, programmed cell death 4. Because increased reactive oxygen species is a common pathologic component in many vascular diseases, the novel findings in the current study suggest that propofol might have some application limitations.
Authors: Y Shi; S Patel; K L Davenpeck; R Niculescu; E Rodriguez; M G Magno; M L Ormont; J D Mannion; A Zalewski Journal: Circulation Date: 2001-05-15 Impact factor: 29.690
Authors: T Kazama; K Takeuchi; K Ikeda; T Ikeda; M Kikura; T Iida; S Suzuki; H Hanai; S Sato Journal: Anesthesiology Date: 2000-09 Impact factor: 7.892
Authors: Seok Man Son; Matthew K Whalin; David G Harrison; W Robert Taylor; Kathy K Griendling Journal: Curr Diab Rep Date: 2004-08 Impact factor: 4.810
Authors: Mang Sun; Lian-Ju Shen; Yang Liu; Qing Yu; Chun-Lan Long; Shang-Ying-Ying Li; Sheng-Fen Tu Journal: Nan Fang Yi Ke Da Xue Xue Bao Date: 2016-02-20
Authors: Christopher G Hughes; Pratik P Pandharipande; Jennifer L Thompson; Rameela Chandrasekhar; Lorraine B Ware; E Wesley Ely; Timothy D Girard Journal: Crit Care Med Date: 2016-09 Impact factor: 7.598